Skip to main content

Updated from 7:09 a.m. EDT

Health care stocks generally have underperformed most other sectors during the last year or two. This underperformance could offer an opportunity for short-squeeze plays from heavily shorted biotechnology, health facilities, pharmaceutical and medical equipment stocks.

A short squeeze takes place when a stock's short-sellers are forced to cover their positions quickly when the stock they are betting against starts climbing on positive news. As the short-sellers are forced to cover, the price of the stock often moves even higher.

The metric for measuring short-squeeze plays is the short ratio, which represents the number of days it would take a stock's short sellers to cover their positions based on the stock's recent average daily trading volume.

Stockpickr has compiled the

Top Health Care Short-Squeeze Plays

, a list of heavily shorted stocks in the sector that have the potential to climb higher on any positive catalyst.

One of the most heavily shorted health care-related stocks is

HealthSouth Corp.


, an inpatient rehabilitation services provider with a short ratio of 40. In 2003, a fraud scheme sent shares plummeting. The company is slated to report its most recent quarterly results on May 7. The stock has a forward price-to-earnings (P/E) ratio of 33 and a P/E-to-growth (PEG) ratio of 6.6.

HealthSouth shares are owned by

Highfields Capital Management

, $8.3 billion hedge fund. Highfields also holds shares of

Clear Channel Communications

(CCU) - Get Compania Cervecerias Unidas S.A. Report

Scroll to Continue

TheStreet Recommends

, which has a 3 short ratio,


(QCOM) - Get QUALCOMM Incorporated Report

, which has a 1.2 short ratio, and

PNC Financial Services

(PNC) - Get PNC Financial Services Group Inc. (The) Report

, with a 3 short ratio.

Another stock with a significant short interest is

Sciele Pharma

( SCRX), a cardiovascular and diabetes pharmaceutical company that has a short ratio of about 18. The company just announced that the Food and Drug Administration has accepted the new-drug application submitted by Addrenex Pharmaceuticals for CloniBID to treat hypertension. Sciele licensed CloniBID from Addrenex for the treatment of hypertension in June 2007. Sciele earlier this week launched a $100 million stock-buyback plan. Sciele has a forward P/E ratio of 8 and a PEG ratio of 0.5.

Sciele appears in the portfolio of the

Stratton Small-Cap Value Fund

, which is rated four stars by Morningstar. Stratton also holds shares of


(CTV) - Get Innovid Corp. Report

, which has a short ratio of 4,

Anixter International

(AXE) - Get Anixter International Inc. Report

, with a short ratio of 10, and


(TEX) - Get Terex Corporation Report

, with a 2.4 short ratio.

Prestige Brands

(PBH) - Get Prestige Consumer Healthcare Inc. Report

is another heavily shorted stock, with a short ratio of 21. This distributor of over-the-counter health-care drugs and personal products has scheduled its earnings call for May 15. The stock has a forward P/E ratio of 12 and a PEG ratio of 1.5.

Prestige stock is owned by

Millennium Partners

, a $5 billion New York hedge fund. Millennium also own shares of


(MO) - Get Altria Group Inc. Report

, which has a short ratio of 0.9,

NRG Energy

(NRG) - Get NRG Energy Inc. Report

, with a 5.4 short ratio, and


(MCK) - Get McKesson Corporation Report

, with a 2.6 short ratio.

For more heavily shorted stocks in the sector, check out the

Top Health-Care Short-Squeeze Plays


At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.

James Altucher is president of


LLC, a wholly owned subsidiary of and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the

Financial Times

and the author of

Trade Like a Hedge Fund


Trade Like Warren Buffett



. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;

click here

to send him an email. has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from